NATCO Pharma and Lupin Receive US FDA Approval for Eribulin Mesylate Injection
NATCO Pharma and Lupin Receive US FDA Approval for Eribulin Mesylate Injection Read Post »
Includes mandatory disclosures submitted to NSE/BSE and SEBI such as shareholding patterns, compliance reports, annual filings, and insider trading disclosures.